Our team

An experienced team of biopharmaceutical leaders

We have assembled a strong scientific, medchem, management, and commercial team based in US, UK and Finland. Our scientific team has published seminal papers on the structural, functional, and biological mechanisms of PP2A inactivation in human cancer.

Management
Sunjeet Sawhney

Sunjeet Sawhney

CEO

Mikko Mannerkoski

Mikko Mannerkoski

CFO

Goutham Narla, M.D., Ph.D.

Goutham Narla, M.D., Ph.D.

Chief Scientific Officer